Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008

(2012) Jennifer A. Schlichting et al.   BREAST CANCER RESEARCH AND TREATMENT

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer

(2011) J. Li et al.   ONCOLOGIST

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

(2010) S. Dawood et al.   ANNALS OF ONCOLOGY

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

(2010) Shaheenah Dawood et al.   CANCER

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data

(2009) Serban Dan Costa et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to Therapy

(2009) Kathryn E. Huber et al.   SEMINARS IN RADIATION ONCOLOGY